Latest filing published 03 Nov 2014 for Boston Scientific CORP.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Uwe E. Reinhardt discloses dealings in 5 companies, chiefly Amerigroup Corp, Boston Scientific Corp and Triad Hospitals Inc. The record holds 31 filings, for trades running from 28 February 2006 to 31 October 2014.
In open-market terms, that means 1 purchase worth €102k on one side and 6 sales worth €4.4M on the other. Sales outweigh purchases by €4.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 19 share grants and 3 option exercises.
The latest filing, published on 3 November 2014, reports a share grant in Boston Scientific Corp. The last purchase on record was published on 2 March 2006, which is 7,540 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations